在主观认知衰退和轻度认知障碍中使用虚拟现实的认知康复:系统性审查
Maria Grazia Maggio1, Raffaela Maione1, Maria Cotelli2
1IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy.
Frontiers in psychology
|September 25, 2025
概括
虚拟现实 (VR) 对轻度认知障碍 (MCI) 和主观认知衰退 (SCD) 的认知训练有希望. 研究表明VR可以改善记忆力,注意力和执行功能,但需要更多的研究.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 康复技术 康复技术 康复技术
背景情况:
- 轻度认知障碍 (MCI) 和主观认知衰退 (SCD) 是痴呆症的前体.
- 虚拟现实 (VR) 是一种新兴的非药物认知训练工具.
- 在MCI和SCD人群中,VR对认知增强的有效性需要系统的评估.
研究的目的:
- 系统地审查基于VR的认知干预对SCD和MCI患者的影响.
- 综合关于VR对这些人群认知功能的有效性的证据.
- 确定当前VR干预研究中的研究差距和方法限制.
主要方法:
- 根据PRISMA指南进行了系统审查.
- 在PubMed,Scopus,Embase和Web of Science中搜索了2019年至2025年间发表的研究.
- 包括的研究包括随机对照试验 (RCT),实验研究和可用性研究,调查SCD和MCI的VR干预.
主要成果:
- 19项研究 (14项RCT,3项实验,2项可用性) 符合纳入标准.
- 在大多数研究中,VR干预显著改善了记忆,注意力和执行功能.
- 报告了高用户参与度,动机,坚持和低退学率,尽管干预协议和结果措施差异很大.
结论:
- 基于VR的认知干预是可行的,并且可能有效地提高MCI的认知功能,有SCD的新兴证据.
- 进一步进行高质量的大规模试验是必要的,以验证研究结果和标准化方案.
- 对SCD人群的VR干预的研究是有限的,需要进一步调查.
相关概念视频
01:30Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
01:22Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K